A couple of stocks that are doing exceptionally well this year are Veru (NASDAQ: VERU) and Chevron (NYSE: CVX). Pharmaceutical company Veru has been among the hottest stocks to own this year, having more than doubled in value while the S&P 500 is firmly in negative territory, down 13%. The company and its investors are hoping that the Food and Drug Administration (FDA) grants it Emergency Use Authorization (EUA) as phase 3 trials have shown it is effective in reducing the risk of death among hospitalized patients.
In this article, we discuss 10 dividend ETFs to buy in August. You can skip our detailed analysis of dividend ETFs and their performance, and go directly to read 5 Dividend ETFs to Buy in August. Investing in dividend exchange-traded funds (ETFs) is a well-known strategy to generate a regular stream of income, especially in […]
As brokers have a deeper understanding of the stocks, one must follow rating upgrades. We select Corteva (CTVA), Clearwater Paper (CLW) and Chevron (CVX) as these witness ratings upgrades.